Clinical trial
Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged…
NCT00329732 · Thomas Jefferson University, Other · Terminated
Key facts
| NCT number | NCT00329732 |
|---|---|
| Title | Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks |
| Official title | Double-Blind, Placebo Controlled Trial Of Greater Occipital Nerve Block For The Treatment Of Migraine Status |
| Lead sponsor | Thomas Jefferson University, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Drug |
| Interventions | 0.5% bupivicaine and 2% lidocaine, Saline placebo |
| Enrollment | 2 |
| Start date | Mar 1, 2006 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | May 25, 2006 |
| Last update posted | May 6, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: